Skip to content

Model 430-01 Biopore Implantable Pacing Lead

by Intermedics, Inc. 510(k)

Active United States

510(k) K862054

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK862054 Date19 Sep 1986ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Model 430-01 Biopore Implantable Pacing Lead is a Permanent Pacemaker Electrode, designed for transvenous implantation to stimulate the heart and regulate cardiac rhythm. Constructed with a biocompatible Biopore coating, it facilitates tissue integration while delivering consistent pacing signals to the right ventricle or atrium, as classified under FDA device code DTB.

This lead is intended for single-use implantation in cardiac electrophysiology procedures, supplied sterile and packaged for surgical use. It is classified as a Class III device under FDA regulations (21 CFR 870.3680) and has received FDA 510(k) clearance via a traditional review pathway, with a decision of Substantially Equivalent by the Cardiovascular Advisory Committee. Compatibility with MRI environments is not specified, and proper handling, storage, and disposal per manufacturer instructions are required.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Model 430-01 Biopore Implantable Pacing Lead, and where is it typically implanted in the body?

    The Model 430-01 Biopore Implantable Pacing Lead is designed for transvenous implantation to stimulate the heart and regulate cardiac rhythm. It is specifically intended for use in the right ventricle or atrium, providing consistent pacing signals while integrating with surrounding tissue thanks to its Biopore coating.

  • Is the Model 430-01 Biopore Implantable Pacing Lead intended for reuse, or is it meant for single-use only?

    The Model 430-01 Biopore Implantable Pacing Lead is explicitly supplied sterile and intended for single-use implantation during cardiac electrophysiology procedures. It is not designed for reuse.

  • How is the Model 430-01 Biopore Implantable Pacing Lead packaged for surgical use, and what regulatory pathway was followed for its clearance?

    The lead is packaged sterile and ready for surgical use, as required for implantable medical devices. It received FDA 510(k) clearance through a traditional review pathway, with a decision of *Substantially Equivalent* by the Cardiovascular Advisory Committee, confirming its compliance with Class III device regulations (21 CFR 870.3680).

  • What special considerations should be taken into account when storing or handling this device?

    The Model 430-01 Biopore Implantable Pacing Lead must be stored and handled according to the manufacturer’s instructions to maintain sterility and integrity. Since it is single-use and intended for surgical implantation, proper packaging should remain unopened until use, and disposal should follow medical device guidelines after implantation.